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1. Functional Magnetic Resonance Imaging (fMRI): localising brain activation
2. fMRI: methodological problems
Small sample sizes (due to cost of fMRI research)
Noisy data (e.g. scanner or physiological artefacts,..)
Multiple testing problem (> 100,000 voxels are
tested simultaneously)
explosion of false positives
stringent thresholding needed to control false
positive rate
most studies become underpowered under
stringent thresholding
3. Meta-analysis
Advantages meta-analysis of fMRI
studies
Aggregation of results ⇒ reproducibility
Increases power
Publication bias
Censored data
Between studies:
studies that fail to show significance in
a certain region fail to get published
studies apply different thresholds to the
data
Within studies:
usually only coordinates of peaks are
reported, the entire SPM is not
available.
Coordinate-based meta-analysis
Activation Likelihood Estimation (ALE) [2,3,4]
4. Gaussian smoothing and union of likelihood of activation
Kernel smoothing captures spatial character of true
activation
Result: maps with modeled activation (MA-maps)
MA-value: for each voxel the probability of an
activation being located at exactly that voxel.
Takes into account location and spatial
uncertainty of reported coordinates of that study.
sample size ↑, spatial uncertainty ↓, FWHM ↓
In the individual studies (MA
maps), all voxels i (i=1,...,V )
have a value between 0 and 1.
A union of these MA-values is
computed to construct the
summary ALE map.
Suppose we have K studies
(k=1,..,K) than the ALE value in
voxel i is equal to
ALEi = 1−
K∏
k=1
(1−MAi,k)
5. Thresholding
Uncorrected or
Account for huge multiple
testing problem through
control of the False
Discovery Rate (FDR).
6. Assessing publication bias?
What happens if null studies are added? How many can be added
without altering the results?
At which point are the results sufficiently robust?
⇔ At which point are the results too lenient? Is the union of
activations too liberal?
7. Simulation study
Assumed activation in a specific
region (target voxel)
3 real studies with peak close to
target voxel in quadrant 1
100 null studies each with 1
peak in quadrants 2-4
Effect of sample size
small (n∼10), medium
(n∼20) or large (n∼30)
Effect of thresholding
uncorrected (p < 0.001)
FDR pID (assumes independent tests or positive
dependence among tests, p < 0.05)
FDR pN (makes no assumptions about
dependencies, more conservative., p < 0.05)
8. Results and discussion
maximum number of studies y that can be added without
altering the results averaged over 1000 simulations
Robustness versus leniency:
What is an acceptable number of null studies
that can be added without altering the
results?
Too low? Points at non-robust results. (In
spirit of classic Fail-Safe N [5])
Too high? One or a small number of
studies drives the analysis.
Results for sample size: contra-intuitive for
robustness but intuitive for leniency.
Would it be more useful to take an average of
MA-values instead of the union (cfr. classic
meta-analysis)?
Employing uncorrected thresholding is
unacceptable
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